Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Leukemia|October 3, 2003
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phaseS Branford, Z Rudzki, A Harper, et al.
Leukemia|May 17, 2003
Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCRC H Hui, K Y Goh, D White, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2007
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphomaF Morschhauser, J F Seymour, H C Kluin-Nelemans, et al.
British Journal of Haematology|March 1, 1997
Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological controlT P Hughes, A Grigg, J Szer, et al.
Bone Marrow Transplantation|November 17, 2009
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantationP J Shaughnessy, B J Bolwell, K van Besien, et al.
Bone Marrow Transplantation|November 21, 2012
IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHDL M Pratt, Y Liu, A Ugarte-Torres, et al.
Internal Medicine Journal|December 9, 2014
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014S Fleming, C K Yannakou, G M Haeusler, et al.
Leukemia Research|March 10, 1999
Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factorJ Morton, P Mollee, K Taylor, et al.
British Journal of Haematology|October 1, 1996
High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study GroupJ Morton, K Taylor, I Bunce, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemiaP Mollee, C Arthur, T Hughes, et al.
Pageof 9